Hims & Hers Health, Inc. HIMS

29.42 0.14 0.48% as of 25 Sep
Market cap
$6.9B
P/E
0.0×
Growth Flags show if company had growth for consecutive years,
Insider Buys alert about insiders buying in the last 12 month

An Income Statement, also known as a Profit and Loss Statement, summarizes a company's revenues, expenses, and profits over a specific period. It highlights how revenue is transformed into net income, showcasing operational efficiency. Key components include total revenue, cost of goods sold (COGS), gross profit, operating expenses, and net profit. Businesses use the Income Statement to assess financial performance, make strategic decisions, and ensure profitability. Investors and stakeholders analyze it to gauge the company’s financial health and future growth potential.

Dec '25 Dec '24 Dec '23 Dec '22 Jan '22 Dec '21 Jan '21 Dec '20 Jan '20 Dec '19
Revenue
2,347.64 1,476.51 872.00 526.92 526.92 271.88 271.88 148.76 148.76 82.56
Revenue Growth
59.00% 69.33% 65.49% 0.00% 93.81% 0.00% 82.77% 0.00% 80.18% (44.50%)
Cost of Revenue
614.26 303.38 157.05 118.19 125.67 67.38 71.46 39.31 40.36 37.95
Gross Profit
1,733.38 1,173.14 714.95 408.72 401.25 204.49 200.42 109.45 108.39 44.61
R&D Expenses
149.30 78.82 48.23 29.24 — 22.38 — 11.24 — —
SG&A Expenses
1,192.02 846.61 576.32 370.78 469.72 249.56 315.46 85.02 123.54 119.02
Operating Income
105.61 61.90 (29.45) (68.70) — (115.04) — (15.14) — (74.41)
Non-operating Income/Expense
18.31 9.81 7.88 2.99 3.07 4.25 (3.36) (2.84) 3.37 2.44
Non-operating Interest Expenses
— — — — — — — 0.01 1.74 0.37
EBT
123.92 71.71 (21.57) (65.71) (65.71) (110.79) (110.79) (17.99) (17.99) (71.97)
Income Tax Provision
(4.44) (54.33) 1.98 (0.03) (0.03) (3.14) (3.14) 0.13 0.13 0.09
Income after Tax
128.37 126.04 (23.55) (65.68) — (107.66) — (18.11) — (72.06)
Net Income Common
128.37 126.04 (23.55) (65.68) (65.68) (107.66) (107.66) (18.11) (18.11) (72.06)
EPS (Basic)
0.57 0.58 (0.11) (0.32) (0.32) (0.58) (0.58) (0.51) (0.51) (2.07)
EPS (Diluted)
0.51 0.53 (0.11) (0.32) (0.32) (0.58) (0.58) (0.51) (0.51) (2.07)
Shares (Basic, Weighted)
224.96 215.94 209.35 204.52 204.52 186.78 186.78 35.35 35.35 34.76
Shares (Diluted, Weighted)
258.23 236.81 209.35 204.52 204.52 186.78 186.78 35.35 35.35 34.76
Gross Margin
73.84% 79.45% 81.99% 77.57% 76.15% 75.22% 73.72% 73.58% 72.87% 54.03%
EBIT Margin
4.50% 4.19% (3.38%) (13.04%) (25.99%) (42.31%) (84.63%) (10.18%) (6.44%) (90.14%)
EBT margin
5.28% 4.86% (2.47%) (12.47%) (12.47%) (40.75%) (40.75%) (12.09%) (12.09%) (87.18%)
Net Profit Margin
5.47% 8.54% (2.70%) (12.46%) (12.46%) (39.60%) (39.60%) (12.18%) (12.18%) (87.29%)
Free Cash Flow Margin
3.15% 14.18% 6.45% (5.55%) (5.04%) (12.96%) (12.66%) (2.83%) (1.67%) (91.06%)
EBITDA
162.61 74.64 (25.62) (61.08) (61.00) (108.66) (110.97) (13.44) (14.09) (74.28)
EBIT
105.61 61.90 (29.45) (68.70) (136.95) (115.04) (230.08) (15.14) (9.58) (74.41)
Income from Continuous Operations
128.37 126.04 (23.55) (65.68) — (107.66) — (18.11) — (72.06)
Consolidated Net Income/Loss
128.37 126.04 (23.55) (65.68) (65.68) (107.66) (107.66) (18.11) (18.11) (72.06)
EPS (Basic, from Continuous Ops)
0.57 0.58 (0.11) (0.32) — (0.58) — (0.51) — (2.07)
EPS (Basic, Consolidated)
0.57 0.58 (0.11) (0.32) — (0.58) — (0.51) — (2.07)
EPS (Diluted, from Cont. Ops)
0.50 0.53 (0.11) (0.32) — (0.58) — (0.51) — (2.07)
Shares (Diluted, Average)
258.23 236.81 209.35 204.52 — 186.78 — 78.05 — —
EPS (Diluted, Consolidated)
0.50 0.53 (0.11) (0.32) — (0.58) — (0.51) — (2.07)
EBITDA Margin
6.93% 5.05% (2.94%) (11.59%) (11.58%) (39.97%) (40.81%) (9.03%) (9.47%) (89.98%)
Operating Cash Flow Margin
12.78% 17.01% 8.43% (5.04%) (5.04%) (12.66%) (12.66%) (1.67%) (1.67%) (90.68%)

Fold the line items

In millions of $ except per-share values · columns are period end dates